Please try another search
Green Lifescience Co., Ltd. engages in development, production, and sale of agrochemical raw materials and pharmaceutical intermediates in South Korea and internationally. The company offers raw materials for pharmaceuticals and pesticides; and primary intermediates to the pharmaceutical and agrochemical markets. It also develops EDP-CL, a piperacillin antibiotic intermediate; N,N-disuccinimidyl carbonate used for the synthesis of HIV treatment; Amoxapine, an antidepressant raw drug, and AM19, an antibiotic intermediate, as well as 1,1'-carbonyldiimidazole, which are coupling reagents used in pharmaceuticals. The company was formerly known as KPX Lifescience.Co.,Ltd. and changed its name to Green Lifescience Co., Ltd. in June 2022. The company was founded in 2005 and is headquartered in Yeosu, South Korea. Green Lifescience Co., Ltd. is a subsidiary of KPX Holdings Co., Ltd.
Name | Age | Since | Title |
---|---|---|---|
Baek-Jae Lee | 56 | - | Director |
Hee-Tae Ahn | 73 | - | Independent Outside Director |
Seong-Jin Kim | 65 | - | Director |
Gyu-Mo Yang | 80 | - | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review